The novel approach of the medication represents a exciting breakthrough in the handling of the condition. Unlike existing drugs, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide125919.fare-blog.com/42425084/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment